Frankfurt - Delayed Quote EUR

NanoRepro AG (NN6.F)

Compare
1.4800
+0.0750
+(5.34%)
As of 10:12:05 AM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,246.6732
3,246.6732
39,002.3620
162,789.4093
16,941.8102
Cost of Revenue
1,353.9311
1,353.9311
26,743.4288
106,146.8980
9,298.8105
Gross Profit
1,892.7421
1,892.7421
12,258.9331
56,642.5113
7,642.9997
Operating Expense
6,334.6806
6,334.6806
6,805.0017
17,117.8244
2,964.4383
Operating Income
-4,441.9386
-4,441.9386
5,453.9315
39,524.6869
4,678.5614
Net Non Operating Interest Income Expense
656.2722
656.2722
4.8558
-52.3527
-17.9471
Pretax Income
-4,684.3170
-4,684.3170
-4,364.1375
38,756.2878
2,780.7375
Tax Provision
--
--
-640.2396
9,032.5258
1,085.4125
Net Income Common Stockholders
-4,685.3010
-4,685.3010
-3,724.2370
29,723.3870
1,694.9499
Diluted NI Available to Com Stockholders
-4,685.3010
-4,685.3010
-3,724.2370
29,723.3870
1,694.9499
Basic EPS
-0.37
-0.37
-0.29
2.30
0.18
Diluted EPS
-0.37
-0.37
-0.29
2.30
0.18
Basic Average Shares
12,713.2220
12,713.2220
12,903.7730
12,903.7730
9,330.7030
Diluted Average Shares
12,713.2220
12,713.2220
12,903.7730
12,903.7730
9,330.7030
Total Operating Income as Reported
-5,340.5892
-5,340.5892
-4,368.9934
38,808.6405
2,798.6846
Total Expenses
7,688.6118
7,688.6118
33,548.4305
123,264.7224
12,263.2488
Net Income from Continuing & Discontinued Operation
-4,684.3170
-4,684.3170
-3,723.8980
29,723.7620
1,695.3249
Normalized Income
-3,785.6664
-3,785.6664
4,657.9575
30,272.9269
2,841.4182
Interest Income
656.2722
656.2722
5.6283
--
0.3526
Interest Expense
--
--
0.7725
52.3527
18.2997
Net Interest Income
656.2722
656.2722
4.8558
-52.3527
-17.9471
EBIT
-4,684.3170
-4,684.3170
-4,363.3650
38,808.6405
2,799.0371
EBITDA
-4,663.2694
-4,663.2694
-4,354.1367
38,818.2405
4,666.2371
Reconciled Cost of Revenue
1,353.9311
1,353.9311
26,743.4288
106,146.8980
9,298.8105
Reconciled Depreciation
21.0000
21.0000
9.2000
9.6000
1,867.2000
Net Income from Continuing Operation Net Minority Interest
-4,684.3170
-4,684.3170
-3,723.8980
29,723.7620
1,695.3249
Total Unusual Items Excluding Goodwill
-898.6506
-898.6506
-9,822.9248
-716.0464
-1,879.8664
Total Unusual Items
-898.6506
-898.6506
-9,822.9248
-716.0464
-1,879.8664
Normalized EBITDA
-3,764.6188
-3,764.6188
5,468.7882
39,534.2869
6,546.1035
Tax Rate for Calcs
--
--
0.0001
0.0002
0.0004
Tax Effect of Unusual Items
--
--
-1,441.0694
-166.8815
-733.7732
12/31/2020 - 10/14/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ESF0.MU Eurofins Scientific SE
50.22
+2.03%
 
IDHCl.XC
 
MVF.AX Monash IVF Group Limited
1.2050
-2.82%
 
DAP.DE Danaher Corporation
235.10
+1.86%
 
VIMIAN.ST Vimian Group AB (publ)
37.35
+0.81%
 
PRM.L Proteome Sciences plc
4.2500
-11.46%
 
GDR.L genedrive plc
2.2500
+4.65%
 
DAP.F Danaher Corporation
234.70
+1.80%
 
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%
 
LZAGY Lonza Group AG
59.17
-2.18%